ITEM 8.01. OTHER INFORMATION
Letter to our Shareholders
We recently filed a Form 8-K with information relative to a temporary suspension imposed by the Securities and Exchange Commission on trading of our stock. We are in the process of addressing the concerns voiced by the SEC and are posting this letter to our Shareholders, attached to this Form 8-K as an exhibit.
Our Mission
To impact global health and well-being, using diagnostics and individualized recommendations, through a new generation of telehealth wearable technologies.
For more information, please visit http://www.kelvinmedical.com/
ITEM 9. FINANCIAL STATEMENTS AND EXHIBITS
INDEX TO EXHIBITS
Exhibit No.
Description
99.1
Letter to our Shareholders
Forward-Looking Statements
Legal Notice Regarding Forward-Looking Statements in this news release that are not historical facts are forward-looking statements that are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined, and assumptions of management. Forward looking statements are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "aims", "potential", "goal", "objective", "prospective", and similar expressions or that events or conditions "will", "would", "may", "can", "could" or "should" occur. Information concerning oil or natural gas reserve estimates may also be deemed to be forward looking statements, as it constitutes a prediction of what might be found to be present when and if a project is actually developed.
Actual results may differ materially from those currently anticipated due to a number of factors beyond the reasonable control of the Company. It is important to note that actual outcomes and the Company's actual results could differ materially from those in such forward-looking statements. Factors that could cause actual results to differ materially include misinterpretation of data, the uncertainty of the requirements demanded by governmental agencies, the Company's ability to raise financing for operations, breach by parties with whom we have contracted, inability to maintain qualified employees or consultants because of compensation or other issues, and successful completion of development programs. Additional information on risks for the Company can be found in the Company's periodic filings filed from time to time with US Securities and Exchange Commission at
www.sec.gov
.
This release does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States.
Media Inquiries
Kelvin Medical, Inc.
http://www.kelvinmedial.com
media.relations@kelvinmedical.com